ChinaDaily Briefs

Daily Brief China: Z.AI, Haitong Unitrust International Financial Leasing, MiniMax, Alibaba, CSPC Innovation Pharmaceutical-A, Zhuhai Kingsware Artificial Intelligence, Linktel Technologies, Shenzhen Transsion Holdings , Hong Kong Exchanges and Clearing and more

In today’s briefing:

  • Quiddity Leaderboard Hang Seng Index Dec26: Z.AI, COSCO, 3SBIO Among Our Top Picks
  • Haitong Unitrust (1905 HK) Halted: Guotai Haitong Takeover Expected
  • Haitong Unitrust (1905 HK): Trading Halt Points to a Likely Privatisation by the Parent
  • MiniMax (100 HK): Synthetic Expert Call Transcript (05 Oct 2026)
  • Alibaba Is Down 27% Even As Cloud Growth Hits 45%—What Is The Market Missing?
  • Aequitas: CSPC Innovation Pharma A/H Listing – 1H26’s Performance Boosted by Licensing Deal
  • Kingsware (金智维) Pre-IPO: Tearsheet
  • Aequtias: Linktel Technologies A/H Listing -Growing Fast but Still a Small Player
  • Transsion Holdings H Share Listing: The Investment Case
  • HKEX (388 HK) Tactical Outlook: Potential Rally


Quiddity Leaderboard Hang Seng Index Dec26: Z.AI, COSCO, 3SBIO Among Our Top Picks

By Janaghan Jeyakumar, CFA

  • The Hang Seng Index is the main benchmark index for Hong Kong stocks. It follows a highly-subjective selection process which makes it difficult to formulaically predict index changes.
  • In this insight, we take a look at a group of names with reasonably high likelihood of getting added/deleted during the next review in December 2026.
  • The results are expected to be confirmed publicly on 20th November 2026.

Haitong Unitrust (1905 HK) Halted: Guotai Haitong Takeover Expected

By David Blennerhassett


Haitong Unitrust (1905 HK): Trading Halt Points to a Likely Privatisation by the Parent

By Arun George

  • Haitong Unitrust International Financial Leasing (1905 HK) halted trading on 5 October pending a takeover announcement. Its parent, Guotai Haitong Securities, owns 85% and will likely take it private.
  • A merger by absorption looks low-risk because no holder has a blocking stake and opposition at the AGM was negligible. A voluntary/delisting offer would face a tougher 90% acceptance hurdle.
  • My valuation methods point to an offer of HK$1.29–1.65 per share, a 7.5%–37.5% premium to the HK$1.20 close. 

MiniMax (100 HK): Synthetic Expert Call Transcript (05 Oct 2026)

By αSK SmartScripts

  • Rapid B2B Pivot: MiniMax is undergoing a massive structural shift; its consumer-facing “emotional companion” story (Talkie, Xingye) has hit a retention wall, prompting a pivot to a low-margin, high-volume B2B “Token selling” model. B2B services grew 703.1% year-on-year to $73.9 million in H1 2026, making up 63.4% of total revenue, while August 2026 ARR reached $800.0 million (with B2B representing roughly 80% of that run-rate).
  • Severe Pricing & Margin Compression: Despite the explosive growth in token consumption (July 2026 consumption was 20 times that of January 2026), fierce pricing wars spearheaded by ByteDance’s Doubao and DeepSeek have gutted pricing power. MiniMax’s H1 2026 gross margin was squeezed to just 17.9%, with adjusted net losses widening 111.2% year-on-year to $293.0 million.
  • Capital Intensity and High Dilution Risks: With H1 2026 R&D expenses scaling to $297.0 million to fund its full-modality pipeline (M3, M3.1-Flash, H3 Video), MiniMax is burning through cash rapidly. Following its January 2026 Hong Kong listing (0100.HK), the stock has crashed from its March peak of HK$1,330.00 to around HK$242.80, evaporating over HK$300.0 billion in market value and turning any upcoming equity placements highly dilutive for existing shareholders.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


Alibaba Is Down 27% Even As Cloud Growth Hits 45%—What Is The Market Missing?

By Baptista Research

  • Alibaba Group has found itself caught in a selloff that has little to do with a sudden collapse in its underlying business.
  • The company’s U.S.-listed shares had fallen roughly 27% year-to-date entering the October 2 session, while its Hong Kong-listed shares dropped about 2.1% on Friday as the Hang Seng Index sank 2.6%, marking its worst one-day performance in more than six months.
  • The immediate culprit was a sharp surge in U.S. Treasury yields, with the benchmark 10-year yield climbing from around 4.6% in late August to above 5.3% by the end of September, its highest level in 24 years.

Aequitas: CSPC Innovation Pharma A/H Listing – 1H26’s Performance Boosted by Licensing Deal

By Hong Jie Seow

  • CSPC Innovation Pharmaceutical-A (300765 CH) CSPC Innovation Pharma aims to raise around US$500m in its H-share listing.
  • CSPC Innovation Pharmaceutical is engaged in the research, development, manufacturing, and sale of caffeine, functional ingredients, consumer nutritional products, and biopharmaceuticals.
  • In this note, we talk about the company’s past performances.

Kingsware (金智维) Pre-IPO: Tearsheet

By Ke Yan, CFA, FRM

  • Kingsware, an AI digital worker and enterprise agent solutions provider, has filed its prospectus with the HKEX. GTJA and BOCI are the joint sponsors.
  • We look at the company’s core segments: the K-APA Solution and the Ki-Agent Solution.
  • We then look at the company’s financial profile, loss-making status, pre-IPO valuation and investor backing.

Aequtias: Linktel Technologies A/H Listing -Growing Fast but Still a Small Player

By Sumeet Singh

  • Linktel Technologies (301205 CH), an optical transceiver provider, aims to raise around US$300m in its H-share listing.
  • Linktel is an optical transceiver provider with integrated capabilities spanning R&D and vertically integrated manufacturing. 
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Transsion Holdings H Share Listing: The Investment Case

By Arun George

  • Shenzhen Transsion Holdings (688036 CH), Africa’s largest smartphone seller, plans to start bookbuilding as early as Wednesday for a US$400–500 million HKEx listing.
  • It sells smartphones and feature phones under the TECNO, Infinix and itel brands, mainly in emerging markets, and is expanding into mobile Internet services and IoT products.
  • The investment case is bearish: Transsion has weak pricing power, memory-exposed margins, and fragile growth outside Africa, while memory stockpiling has turned 1H26 free cash flow sharply negative.

HKEX (388 HK) Tactical Outlook: Potential Rally

By Nico Rosti

  • Hong Kong Exchanges and Clearing (388 HK) has corrected 11% in the last few weeks, but its most significant last peak was in August 2025. 
  • The main hypothesis of this insight is that the stock may offer a short-term asymmetric LONG opportunity, to profit from a counter rally.
  • Analysis conducted with out quantitative model show that last week’s correction was shallow so the stock could go lower, but it should be bottoming soon. Broader consensus: strong buy.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars